STOCKHOLDERS EQUITY (Details 1) - Stock Warrants [Member] |
3 Months Ended |
|---|---|
|
Mar. 31, 2026
$ / shares
shares
| |
| Outstanding, Beginning balance | shares | 6,935,682 |
| Outstanding, Ending balance | shares | 6,935,682 |
| Exercisable, ending balance | shares | 6,935,682 |
| Weighted Average Grant Date Fair Value, Outstanding, Beginning balance | $ 4.21 |
| Weighted Average Grant Date Fair Value, Granted | 0 |
| Weighted Average Grant Date Fair Value, Exercised | 0 |
| Weighted Average Grant Date Fair Value, Forfeited and cancelled | 0 |
| Weighted Average Grant Date Fair Value, Ending Balance | 4.21 |
| Weighted Average Grant Date Fair Value, Exercisable Ending Balance | 4.21 |
| Weighted average exercise price, Beginning balance | 2.54 |
| Weighted Average Exercise price, Granted | 0 |
| Weighted Average Exercise price, Exercised | 0 |
| Weighted Average Exercise price, Forfeited and cancelled | 0 |
| Weighted average exercise price, ending balance | 2.54 |
| Exercisable, Weighted average exercise price, ending balance | $ 2.54 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|